MedStar Health News

At CROI2017, MedStar Health Research Institute researchers presented new data on hepatitis C virus (HCV)-positive non-baby boomers.

Neil Weissman, MD, commented on the U.S. Food and Drug Administration (FDA) approval of an important label update for an echocardiogram contrast agent.

Suzanne Groah, MD, Director of the Spinal Cord Injury Consultation Liaison Service and of Spinal Cord Injury Research at MedStar National Rehabilitation Hospital and Associate Professor of Rehabilitation Medicine at Georgetown University recently received an exciting new grant award for field initiated research from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR).

Absorb™ Stent Opens Clogged Arteries, then Gradually Dissolves in the Body Washington, D.C., August 30, 2016 – A heart stent that slowly dissolves into the body is now available for patients with clo...

The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.

The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.